Trump announces efforts to expand access to IVF drugs

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC, on Oct. 16, 2025. Andrew Caballero-Reynolds | AFP | Getty Images President Donald Trump on Thursday announced two new efforts to expand the availability of in vitro fertilization, the first concrete step from his administration on the expensive…

Read More

Trump reaches drug pricing deal with AstraZeneca

U.S. President Donald Trump participates in a bilateral meeting with Finland’s President Alexander Stubb (not pictured), in the Oval office at the White House in Washington, D.C., U.S., Oct. 9, 2025. Nathan Howard | Reuters The Trump administration and AstraZeneca announced Friday they have reached an agreement for the U.K.-based pharmaceutical giant to cut drug…

Read More

Amgen, other drugmakers launch DTC programs

The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients…

Read More

RFK Jr. vaccine panel Covid shot recommendations

Members of the Advisory Committee on Immunization Practices listen to a presentation about Covid-19 during an ACIP meeting at the Centers for Disease Control and Prevention in Atlanta, Sept. 19, 2025. Alyssa Pointer | Reuters Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine panel on Friday weakened Covid shot recommendations in the…

Read More

The vaccine and public health debate explained

The exterior of the Center for Disease Control and Prevention (CDC) main campus in Atlanta, Georgia, U.S., Aug. 27, 2025. Alyssa Pointer | Reuters The Centers for Disease Control and Prevention is facing a leadership upheaval — and at the center of the shakeup is concern about the agency’s approach to vaccines and U.S. public…

Read More